Abstract:Rationale: Sickle cell disease (SCD) is a monogenetic condition with recurring vaso-occlusive events causing lifelong pulmonary morbidity and mortality. There is increasing access to curative therapies, such as hematopoietic cell transplant (HCT), for people living with SCD. However, more information on pulmonary function in adults with SCD after HCT is needed in order to best guide decisions for HCT and post-HCT care. Objective: To test the hypothesis that forced expiratory volume in one second (FEV1), and other pulmonary function testing (PFT) parameters, remain stable three years post-HCT. Methods: People living with SCD undergoing non-myeloablative HCT in a prospective cohort at the NIH Clinical Center from 2004 - 2019 were evaluated for enrollment. Global Lung Function Initiative reference equations and descriptive statistics were calculated prior to HCT and annually for three years. Six-minute walk distance (6MWD) testing was performed. Generalized estimating equations (GEE) were employed to evaluate inter-individual changes in PFT parameters and 6MWD. Results: Of 97 SCD patients undergoing HCT, 41 (42%) were female with median (25th, 75th percentile) age 31.8 (24.8, 38.0) years. Each year of measurement included the following numbers of subjects available for analysis with PFTs: baseline (97), year 1 (91), year 2 (72), year 3 (55); and the following numbers of subjects available for analysis with 6MWD: baseline (79), year 1 (73), year 2 (57), year 3 (41). Pre-HCT FEV1 was median (25th, 75th percentile) 68.3% (61.3%, 80.3%) and 69.2% (60.8%, 77.7%) three years post-HCT; pre-HCT DLCO 60.5% (53.0%, 66.3%) and 64.6% (55.1%, 73.4%) three years post-HCT. GEE estimated that DLCO %-predicted increased significantly 3.7% (95% confidence interval, 1.0%, 6.3%) and the 6MWD significantly increased by 25.9 (6.6, 45.2) meters three years post-HCT, while there was no significant change in %-predicted FEV1 or FVC compared to pre-HCT. Conclusions: Overall, PFTs remained stable and there was an improvement in DLCO and 6MWD in this predominantly adult cohort undergoing non-myeloablative HCT for SCD. Allogeneic HCT for SCD may cease the cycle of vaso-occlusive pulmonary injury and prevent continued damage. Multicenter studies are needed to evaluate the long-term lung health effects of HCT for SCD in adults and children.

Effects of pulmonary rehabilitation in hematopoietic stem cell transplantation recipients: a randomized controlled study

A Pilot Randomized Controlled Trial of Prehabilitation Exercise for Adult Hematopoietic Stem Cell Transplant Recipients

"Prehabilitation" for Pediatric Patients With Cancer Before Undergoing Hematopoietic Stem Cell Transplantation

Effectiveness of exercise rehabilitation on aplastic anemia patients receiving hematopoietic stem cell transplantation: study protocol for a randomized controlled trial

Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation

Effects of comprehensive and intensive pulmonary rehabilitation and nutritional support on quality of life and functional status in patients with chronic obstructive pulmonary disease

Influencing factors of cardiorespiratory fitness in allogeneic stem cell transplant candidates prior to transplantation

Longitudinal Analysis of the Relationships Between Social Support and Health-Related Quality of Life in Hematopoietic Stem Cell Transplant Recipients

Impact of pulmonary rehabilitation on exercise capacity, health-related quality of life, and cardiopulmonary function in lung surgery patients: a retrospective propensity score-matched analysis

Pulmonary Function After Non-Myeloablative Hematopoietic Cell Transplant for Sickle Cell Disease

Pulmonary rehabilitation improves exercise capacity, health-related quality of life, and cardiopulmonary function in patients with non-small cell lung cancer

Randomized Controlled Trial of a Virtually Delivered Exercise and Stress Management Program to Improve Physical Performance of Hematopoietic Cell Transplant Survivors

Effects of exercise interventions for physical fitness, fatigue, and quality of life in adult hematologic malignancy patients without receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis

Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study

The Role of Outpatient Physical Medicine and Rehabilitation in a Multidisciplinary Prehabilitation Program for Older Adults before Allogeneic Hematopoietic Stem Cell Transplant

Pulmonary Function in Pediatric Stem Cell Transplantation

633 THE EFFECTS OF AEROBIC EXERCISE TRAINING ON CARDIOPULMONARY EXERCISE TESTING AND HEART FAILURE BIOMARKERS IN ADULT PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME AND FONTAN CIRCULATION

Health-Related Quality of Life and Personal Life Goals of Adults With Sickle Cell Disease After Hematopoietic Stem Cell Transplantation

Effects of exercise-based home pulmonary rehabilitation on patients with chronic obstructive pulmonary disease: An overview of systematic review

Quality of Life of Hematological Neoplasm Survivors After Hematopoietic Stem Cell Transplantation

The effect of pulmonary rehabilitation on quality of life and functional capacity after chemotherapy in patients with small cell lung cancer